Jpmorgan Chase & CO BRIDGEBIO PHARMA INC Transaction History

Jpmorgan Chase & CO

2,706,000

Previous 1,321,000 104.84%

Previous $0 NaN%

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	N/A	1,385,000 Added 104.84%	2,706,000 $0
Q3 2024 Dec 26, 2024	BUY	N/A	735,000 Added 125.43%	1,321,000 $0
Q3 2024 Nov 08, 2024	BUY	N/A	735,000 Added 125.43%	1,321,000 $0
Q2 2024 Dec 26, 2024	SELL	N/A	-735,000 Reduced 55.64%	586,000 $0
Q2 2024 Aug 12, 2024	SELL	N/A	-3,367,000 Reduced 85.18%	586,000 $0
Q1 2024 Dec 26, 2024	BUY	N/A	2,632,000 Added 199.24%	3,953,000 $0
Q1 2024 May 10, 2024	BUY	N/A	1,697,000 Added 75.22%	3,953,000 $0
Q4 2023 Dec 26, 2024	BUY	N/A	935,000 Added 70.78%	2,256,000 $0
Q4 2023 Feb 12, 2024	BUY	N/A	161,000 Added 7.68%	2,256,000 $0
Q3 2023 Nov 14, 2023	SELL	N/A	-784,000 Reduced 27.23%	2,095,000 $0
Q2 2023 Aug 11, 2023	BUY	N/A	250,000 Added 9.51%	2,879,000 $0
Q1 2023 May 11, 2023	BUY	N/A	1,700,000 Added 182.99%	2,629,000 $0
Q2 2022 Aug 11, 2022	SELL	N/A	-300,000 Reduced 24.41%	929,000 $376,000
Q1 2022 May 11, 2022	BUY	N/A	1,229,000 New	1,229,000 $593,000

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.